Literature DB >> 3311162

trans-Diamminedichloroplatinum(II), a reversible RNA-protein cross-linking agent. Application to the ribosome and to an aminoacyl-tRNA synthetase/tRNA complex.

M A Tukalo1, M D Kubler, D Kern, M Mougel, C Ehresmann, J P Ebel, B Ehresmann, R Giegé.   

Abstract

A new approach allowing detection of contact points between RNAs and proteins has been developed using trans-diamminedichloroplatinum(II) as the cross-linking reagent. The advantage of the method relies on the fact that the coordination bonds between platinum and the potential acceptors on proteins and nucleic acids (mainly S of cysteine or methionine residues; N of imidazole rings in histidine residues; N7 of guanine, N1 of adenine, and N3 of cytosine residues) can be reversed, so that the cross-linked oligonucleotides or peptides in contact within a complex can be analyzed directly. The method was worked out with the ribosome from Escherichia coli and the tRNAVal/valyl-tRNA synthetase system from the yeast Saccharomyces cerevisiae. In the first system the platinum approach permitted detection of ribosomal proteins cross-linked to 16S rRNA within the 30S subunits (mainly S18 and to a lower extent S3, S4, S11, and S13/S14); in the second system major oligonucleotides of tRNAVal cross-linked to valyl-tRNA synthetase were detected in the anticodon stem and loop, in the variable loop, and in the 3' terminal amino acid accepting region. These results are discussed in light of the current knowledge on ribosome and tRNAs and of potential applications of the methodology.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3311162     DOI: 10.1021/bi00390a045

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Site-specific platinum(II) cross-linking in a ribozyme active site.

Authors:  Erich G Chapman; Victoria J DeRose
Journal:  J Am Chem Soc       Date:  2011-12-14       Impact factor: 15.419

2.  Crosslinking of tRNA containing a long extra arm to elongation factor Tu by trans-diamminedichloroplatinum(II).

Authors:  N J Rasmussen; F P Wikman; B F Clark
Journal:  Nucleic Acids Res       Date:  1990-08-25       Impact factor: 16.971

3.  Crosslinking of transcription factor TFIIIA to ribosomal 5S RNA from X. laevis by trans-diamminedichloroplatinum (II).

Authors:  F Baudin; P Romby; P J Romaniuk; B Ehresmann; C Ehresmann
Journal:  Nucleic Acids Res       Date:  1989-12-11       Impact factor: 16.971

4.  cis elements and trans-acting factors involved in dimer formation of murine leukemia virus RNA.

Authors:  A C Prats; C Roy; P A Wang; M Erard; V Housset; C Gabus; C Paoletti; J L Darlix
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

5.  Interaction of HIV-1 reverse transcriptase with a synthetic form of its replication primer, tRNA(Lys,3).

Authors:  C Barat; S F Le Grice; J L Darlix
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

6.  Towards Antitumor Active trans-Platinum Compounds.

Authors:  Sheena M Aris; Nicholas P Farrell
Journal:  Eur J Inorg Chem       Date:  2009-04-01       Impact factor: 2.524

7.  HIV-1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA.

Authors:  C Barat; V Lullien; O Schatz; G Keith; M T Nugeyre; F Grüninger-Leitch; F Barré-Sinoussi; S F LeGrice; J L Darlix
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.